Ultragenyx Logo

About Chiesi Global Rare Diseases

Chiesi Global Rare Diseases is a business unit of the Chiesi Group established in February 2020 and focused on research and development of treatments for rare and ultra-rare disorders. The Global Rare Diseases unit works in collaboration with Chiesi Group to harness the full resources and capabilities of our global network to bring innovative new treatment options to people living with rare diseases, many of whom have limited or no treatments available. The unit is also a dedicated partner with global leaders in patient advocacy, research and patient care. For more information visit www.chiesiglobalrarediseases.com

About Chiesi Group

Based in Parma, Italy, Chiesi Farmaceutici is an international research-focused healthcare group with 85 years of experience in the pharmaceutical industry and a global presence in 29 countries. Chiesi researches, develops, and markets innovative drugs in the respiratory therapeutics, specialist medicine, and rare disease areas. Its R&D organization is headquartered in Parma (Italy), and is integrated with R&D groups in France, the USA, the UK, and Sweden to advance Chiesi's pre-clinical, clinical, and registration programs. Chiesi employs nearly 6,000 people. Chiesi Group is a certified Benefit Corporation. For more information www.chiesi.com.

Get in touch

Brita Forsberg
Brita ForsbergSenior MSL Rare Diseases
Chiesi Pharma AB
    Francesca Donà
    Francesca DonàMedical Manager Rare Disease - Europe and Emerging Markets
    Chiesi Global Rare Disease
      Sioned LLoyd
      Sioned LLoydTherapy Area Lead Rare Disease
      Chiesi Ltd
        Giada Di Rosario
        Giada Di RosarioGlobal Brand Leader - Europe and Emerging
        Chiesi Global Rare Disease Markets
          Birte Weselmann
          Birte WeselmannMedical Manager Rare Diseases
          Chiesi GmbH